Hirofumi Ohtani

  • Speciality: Cardiology
  • Country: IT
  • Working place: Humanitas Clinical and Research Institute, Milan, IT

Activities

Comment on Jun 12, 2018

Hirofumi Ohtani replied to your comment on presentation Fully Percutaneous Transaxillary Transcatheter Aortic Valve Implantation in patients with a patent left internal mammary graft.

»Thank you for the questions. 1) selfexpandable stents as viaban or fluency are definitely preferable. At the moment of the interventions we did not have the correct size. Corrective action: Now we have them on the shelf!!! 2) to puncture under eco and fluoro+contrast guidance in the more distal portion of the axillary artery. Also, theoretically, the proglide pre-closure is little traumatic to the vessel.«
Comment on Jun 11, 2018

Konstantinos Stavroulakis commented on presentation Fully Percutaneous Transaxillary Transcatheter Aortic Valve Implantation in patients with a patent left internal mammary graft.

»Excellent presentation of a challenging case. I have only 2 questions: 1) Do you have any concerns regarding the deployment of a balloon expandable covered stent in an area exposed to high mechanical stress? 2) Median nerve injury can be a major complication of a percutaneous transaxillary access. Which is your strategy/approach in order to avoid it?«
Comment on Jun 11, 2018

Özgün Sensebat commented on presentation Fully Percutaneous Transaxillary Transcatheter Aortic Valve Implantation in patients with a patent left internal mammary graft.

»Thank you Hirofumi Ohtani for your tremendous presentation. I totally agree with the potential for a valuable arterial access. Your experience is also important for CMD-BEVAR or T-branch Devices. One question: would it be possible to use Prostar XL instead of ProGlide if the vessel diameter is big enough? Regards«
Case report

Fully Percutaneous Transaxillary Transcatheter Aortic Valve Implantation in patients with a patent left internal mammary graft

We report a clinical experience with fully percutaneous transaxillary TAVI in patients with a patent left internal mammary graft.

Hirofumi Ohtani
June 11, 2018 6 Comments
Show presentation